Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $123.52 | 6 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $82.38 | 4 | $0 (2020) |
| Abbott Laboratories | $41.14 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $18.86 | 1 | Abbott Laboratories ($18.86) |
| 2022 | $22.28 | 1 | Abbott Laboratories ($22.28) |
| 2020 | $51.69 | 2 | Novartis Pharmaceuticals Corporation ($51.69) |
| 2019 | $30.69 | 2 | Novartis Pharmaceuticals Corporation ($30.69) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/18/2023 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/28/2022 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Cardiac Rhythm Management | ||||||
| 02/13/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $38.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/16/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 4,462 | 6,292 | $2.0M | $443,265 |
| 2022 | 21 | 3,910 | 5,390 | $1.5M | $370,259 |
| 2021 | 21 | 3,986 | 5,615 | $1.4M | $385,417 |
| 2020 | 22 | 3,170 | 4,493 | $1.2M | $308,319 |
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 795 | 1,486 | $445,800 | $151,676 | 34.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 236 | 237 | $568,800 | $90,019 | 15.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 347 | 353 | $370,650 | $56,115 | 15.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 181 | 722 | $58,000 | $30,676 | 52.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 157 | 157 | $70,650 | $20,750 | 29.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 236 | 241 | $71,100 | $15,853 | 22.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 264 | 265 | $79,500 | $14,202 | 17.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 241 | 244 | $146,400 | $13,514 | 9.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 112 | 112 | $42,000 | $12,006 | 28.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 92 | 169 | $34,000 | $11,201 | 32.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 714 | 782 | $54,740 | $9,172 | 16.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 692 | 875 | $30,625 | $5,981 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 55 | $11,000 | $3,808 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $8,125 | $2,225 | 27.4% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 126 | 235 | $12,925 | $2,080 | 16.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 14 | $2,240 | $1,524 | 68.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 131 | 265 | $3,975 | $1,113 | 28.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 11 | 12 | $4,200 | $974.01 | 23.2% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 13 | 13 | $2,470 | $261.97 | 10.6% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 11 | 11 | $1,100 | $66.11 | 6.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 19 | 19 | $3,040 | $48.45 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 767 | 1,417 | $381,350 | $141,095 | 37.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 133 | 133 | $264,000 | $52,243 | 19.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 275 | 276 | $289,800 | $45,457 | 15.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 123 | 486 | $38,880 | $23,569 | 60.6% |
About Dr. Keith Friedman, MD
Dr. Keith Friedman, MD is a Cardiovascular Disease healthcare provider based in Columbia, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194793877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Friedman, MD has received a total of $123.52 in payments from pharmaceutical and medical device companies, with $18.86 received in 2023. These payments were reported across 6 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($123.52).
As a Medicare-enrolled provider, Friedman has provided services to 15,528 Medicare beneficiaries, totaling 21,790 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Columbia, MD
- Active Since 03/09/2006
- Last Updated 10/10/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1194793877
Products in Payments
- ENTRESTO (Drug) $82.38
- CONFIRM RX (Device) $41.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Columbia
Dr. Patrick Mccann, M.d, M.D
Cardiovascular Disease — Payments: $687,373
Dr. James Fairlamb, M.d, M.D
Cardiovascular Disease — Payments: $450,127
Taishi Hirai, Md, MD
Cardiovascular Disease — Payments: $164,143
Dr. Sultan Siddique, M.d, M.D
Cardiovascular Disease — Payments: $123,448
Dr. James Ampadu, M.d, M.D
Cardiovascular Disease — Payments: $78,753
Michael Cryer, M.d, M.D
Cardiovascular Disease — Payments: $75,074